Compounds That Target LIMK2

LIM domain kinase 2 · 29 compounds in BiohacksAI corpus

LIMK2 (LIM domain kinase 2) is a biological target with 29 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into LIMK2 modulation for therapeutic and biohacking applications.

View LIMK2 target page →UniProt: P53671 ↗

Most Studied Compounds for LIMK2

Sorafenib

300+

studies

Dasatinib

299+

studies

Crizotinib

298+

studies

All 29 Compounds — Ranked by Evidence

Foretinib

4.34

confidence

Tozasertib

4.33

confidence

Pi 103

4.17

confidence

Pazopanib

3.69

confidence

Tae 684

3.43

confidence

Fedratinib

3.40

confidence

Linifanib

3.33

confidence

Dabrafenib

3.30

confidence

Jnj 7706621

3.09

confidence

At 9283

3.09

confidence

Pacritinib

3.04

confidence

Danusertib

2.94

confidence

R 406

2.83

confidence

Capivasertib

2.77

confidence

Plx 4720

2.71

confidence

Ast 487

2.56

confidence

Damnacanthal

2.56

confidence

Aee 788

2.30

confidence

Pha 680632

2.30

confidence

Rebastinib

2.20

confidence

Encorafenib

2.20

confidence

Gandotinib

2.20

confidence

Cyc 116

2.08

confidence

Asp 3026

2.08

confidence

Tanzisertib

1.95

confidence

Lx 7101

1.95

confidence

Crizotinib

298+

studies

1.10

confidence

Dasatinib

299+

studies

0.69

confidence

Sorafenib

300+

studies

0.69

confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for LIMK2 (LIM domain kinase 2). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: LIMK2 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.